7.8494

0.90% 0.0794

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $7.8494, with a volume of 838.30K. It is up +0.90% in the last 24 hours and down -0.63% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Previous Close:

$7.77

Open:

$7.62

24h Volume:

838.30K

Relative Volume:

0.45

Market Cap:

$1.09B

Revenue:

$288.95M

Net Income/Loss:

$-119.03M

P/E Ratio:

13.78

EPS:

0.5695

Net Cash Flow:

$60.67M

1W Performance:

+10.27%

1M Performance:

-0.63%

6M Performance:

-12.60%

1Y Performance:

+13.62%

1-Day Range:

$7.61

$7.93

1-Week Range:

$7.08

$7.93

52-Week Range:

$4.52

$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

580

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

MRVI's Discussions on Twitter

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

10:46 AM

(MRVI) Investment Analysis and Advice - Stock Traders Daily

10:46 AM

Nov 04, 2024

MRVI Stock Surges Amid Biotechnology Sector Fluctuations - GuruFocus.com

Nov 04, 2024

Nov 03, 2024

Cannon Global Investment Management LLC Makes New $590,000 Investment in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Nov 03, 2024

Oct 31, 2024

Roubaix Capital LLC Trims Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Oct 31, 2024

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat

Oct 31, 2024

Maravai LifeSciences (MRVI) to Release Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 30, 2024

Maravai LifeSciences (NASDAQ:MRVI) Trading Up 7%Still a Buy? - MarketBeat

Oct 30, 2024

Oct 29, 2024

Millennium Management LLC Adjusts Stake in Maravai LifeSciences Holdings Inc - GuruFocus.com

Oct 29, 2024

Oct 28, 2024

Where Do Analysts See Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Heading? - Stocks Register

Oct 28, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $10.67 Average PT from Brokerages - MarketBeat

Oct 28, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Oct 28, 2024

Oct 25, 2024

(MRVI) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 25, 2024

Oct 22, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.6%Here's Why - MarketBeat

Oct 22, 2024

Oct 18, 2024

43,372 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Bought by The Manufacturers Life Insurance Company - Defense World

Oct 18, 2024

Oct 17, 2024

Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat

Oct 17, 2024

Oct 15, 2024

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 - GlobeNewswire

Oct 15, 2024